Publication | Closed Access
Phase I evaluation of seliciclib (R-roscovitine), a novel oral cyclin-dependent kinase inhibitor, in patients with advanced malignancies
164
Citations
21
References
2010
Year
MedicinePharmacologyPharmacotherapyAnti-cancer AgentAdvanced MalignanciesCancer TreatmentOncologyRadiation OncologyCancer ResearchDrug Discovery
| Year | Citations | |
|---|---|---|
Page 1
Page 1